Table 3 Self-Reported symptoms by SARS-CoV-2 IgG status.

From: Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts

Symptoms

Total

n (column %)

SARS-CoV-2 IgG Status

p-value

(all data)

Positive

n (row %)

Negative

n (row %)

Total

1743

95 (5.5%)

1648 (94.5%)

Ā 

Fever**

252 (14.5%)

43 (17.1%)

209 (82.9%)

p < 0.001†*

Sore throat***

608 (34.9%)

33 (5.4%)

575 (94.6%)

p < 0.001*

Cough

611 (35.1%)

45 (7.4%)

566 (92.6%)

0.02*

Runny nose

672 (38.6%)

32 (4.8%)

640 (95.2%)

0.39

Shortness of breath

280 (16.1%)

30 (10.7%)

250 (89.3%)

p < 0.001*

Chills

362 (20.8%)

43 (11.9%)

319 (88.1%)

p < 0.001†*

Nausea/vomiting

318 (18.2%)

16 (5.0%)

302 (95.0%)

0.83

Diarrhea

409 (23.5%)

26 (6.4%)

383 (93.6%)

0.43

Headache

869 (49.9%)

49 (5.6%)

820 (94.4%)

0.81

Rash

73 (4.2%)

3 (4.1%)

70 (95.9%)

0.79†

Muscle/joint pain

566 (32.5%)

56 (9.9%)

510 (90.1%)

p < 0.001*

Loss of appetite

285 (16.4%)

36 (12.6%)

249 (87.4%)

p < 0.001*

Loss of Smell/Taste

116 (6.7%)

44 (37.9%)

72 (62.1%)

p < 0.001*

Fatigue

815 (46.8%)

64 (7.9%)

751 (92.1%)

p < 0.001*

Seizures

5 (0.3%)

0

5 (100%)

1.00†

Altered consciousness

9 (0.5%)

2 (22.2%)

7 (77.8%)

0.08†

Other neurological signs

21 (1.2%)

5 (23.8%)

16 (76.2%)

0.0045†*

  1. †Fisher’s Exact Test, otherwise, Chi Squared.
  2. *Statistically significant when p-value < 0.05.
  3. **Missing data included in analysis due to accounting for 5.2% of responses.
  4. ***Missing data included in analysis due to accounting for 5.3% of responses.
  5. Column percentages may not always add up to 100% due to missing data. Missing data ranged from 0–1.03%.